NCT02790073

Phase 2 Study With SNF472 in Calciphylaxis Patients

Phase 2 Open Label Single Arm Repeat Dose Study to Assess the Effect of SNF472 on Wound Healing in Uraemic Calciphylaxis Patients

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 14 (actual)
• Sponsor: Sanifit Therapeutics S. A. · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To evaluate the effect of SNF472 on top of standard of care on promoting wound healing and other parameters of therapeutic response in haemodialysis patients with calciphylaxis (calcific uraemic arteriolopathy, CUA).

Conditions

• Calciphylaxis
• Calcific Uremic Arteriolopathy

Interventions

Type	Name	Description
DRUG	SNF472	SNF472 for calciphylaxis

Timeline

• Start date: 2016-05-01
• Primary completion: 2017-11-15
• Completion: 2017-11-15
• First posted: 2016-06-03
• Last updated: 2019-08-28
• Results posted: 2019-08-28

Locations

3 sites across 2 countries: United States, United Kingdom